Susquehanna International Group’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6K Buy
25,500
+7,045
+38% +$32.1K ﹤0.01% 12872
2025
Q4
$103K Buy
18,455
+17,780
+2,634% +$198K ﹤0.01% 11434
2025
Q3
$5K Buy
675
+85
+14% +$722 ﹤0.01% 12132
2025
Q2
$4.48K Sell
590
-265
-31% -$4.13K ﹤0.01% 12448
2025
Q1
$16.2K Sell
855
-11,190
-93% -$352K ﹤0.01% 12164
2024
Q4
$436K Buy
12,045
+11,050
+1,111% +$308K ﹤0.01% 9013
2024
Q3
$28.7K Sell
995
-785
-44% -$17.4K ﹤0.01% 11543
2024
Q2
$45.6K Sell
1,780
-935
-34% -$42.5K ﹤0.01% 11452
2024
Q1
$205K Sell
2,715
-14,685
-84% -$1.16M ﹤0.01% 10549
2023
Q4
$1.79M Sell
17,400
-5,455
-24% -$490K ﹤0.01% 5602
2023
Q3
$2.23M Buy
22,855
+15,225
+200% +$1.42M ﹤0.01% 4914
2023
Q2
$894K Buy
7,630
+1,605
+27% +$203K ﹤0.01% 6958
2023
Q1
$505K Buy
6,025
+1,455
+32% +$127K ﹤0.01% 8540
2022
Q4
$388K Sell
4,570
-840
-16% -$64.1K ﹤0.01% 8459
2022
Q3
$172K Buy
+5,410
New +$149K ﹤0.01% 11058

Other funds holding RVPH

Susquehanna International Group's RVPH Position: Q1 2026 in Review

Susquehanna International Group sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2026, closing a stake of 34,103 shares — an estimated $155K sold.

Susquehanna International Group first reported a position in RVPH in Q3 2021 and held it in 15 quarters. The position peaked at $1.06M in Q4 2023. 35 funds tracked by Wall St. Rank hold RVPH as of Q1 2026.

  • Susquehanna International Group reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2026 after selling out during the quarter.
  • Susquehanna International Group sold 34,103 REVIVA PHARMA HLDGS INC shares in Q1 2026, an estimated $155K.
  • Susquehanna International Group first reported a position in REVIVA PHARMA HLDGS INC in Q3 2021 and held it in 15 quarters.
  • Susquehanna International Group's REVIVA PHARMA HLDGS INC position peaked at $1.06M in Q4 2023.
  • 35 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.